LUCD

Lucid Diagnostics Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 4/10
  • Momentum↑ 7/10
Lucid Diagnostics sales and earnings growth
LUCD Growth
Neutral
  • Revenue Y/Y↑ 5.01%
  • EPS Y/Y↑ 22.12%
  • FCF Y/Y↓ 0.62%
Lucid Diagnostics gross and profit margin trends
LUCD Profitability
Low
  • Gross margin ↓ -58.10%
  • EPS margin↓ -1496.80%
  • ROIC↓ -1081.40%
Lucid Diagnostics net debt vs free cash flow
LUCD Risk
Great
  • Debt / Equity↓ 0.9
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -2219.2

Lucid Diagnostics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Devices stocks ↗